Ref. Ares(2015)3867489 - 18/09/2015
Ref. Ares(2017)3665888 - 20/07/2017
Directorate-General for Trade
Directorate A - Resources, Information and Policy Coordination Information, Communication and Civil Society
Brussels, 18 September 2015
Meeting on 14 September 2015 between COM and PAN Europe on endocrine
disruptors, chemicals and TTIP to clarify the scope of an access to documents
request from PAN (2015/3059)
from PAN Europe;
from DG ENV,
from DG SANTE and
from DG TRADE
COM (4.1b ) explained that endocrine disruptors (
) issue is not one of the pilot projects
in the Trans-Atlantic Trade and Investment Partnership (TTIP) agreement negotiations.
EDs are discussed between EU and US in the framework of the bilateral cooperation lead
by DG ENV. PAN took note of this and has in fact already introduced an access to
documents request on the bilateral cooperation to DG ENV. PAN wanted to know if
there are any project of possible EU-US harmonization on pesticides, stating that the list
of banned substances in the EU still includes some that are allowed in the US. COM
) replied that we are not talking about harmonization of pesticides: there is no
regulatory co-operation on the basis of TTIP as the agreement is not yet in force.
) explained that the exchange and an open discussion on ED issues with the US
started two years ago and one meeting was held in 2014, next workshop is on 6-7
October 2015. These meetings are between government authorities and they concentrate
e.g. on prioritization and risk assessment. COM (
) added that DG SANTE is also
attending these events and that the focus of these events is on scientific research.
Regulatory approach is very different in the US and in the EU: in the US the focus is on
screening the universe of chemicals and searching for priorities for further testing; in the
EU, some pieces of legislation require to set scientific criteria to identify endocrine
disruptors and the regulatory consequences for those substances are already defined.
PAN noted that there is an Endocrine Disruptors Screening Program (EDSP) in the US.
PAN then continued that they are interested in the technical part of the discussion, the
methodology and processes – meaning documents that would give more detail than what
is currently available publicly, on the TTIP website for example. In the exchange of
information, also harmonization of standards is discussed. COM (
) explained that, at
the level of the Organization for Economic Cooperation and Development (OECD), there
is ongoing work on harmonization of test methodology and testing strategies for the
hazard identification and assessment of chemicals, including endocrine disruptors. But no
decisions about harmonization of regulatory approaches on endocrine disruptors are
foreseen or are under discussion in any of the ongoing bilateral EU-US cooperation.
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111
Office: CHAR 7/013
In conclusion, PAN agreed to review the scope of their request, indicating that "EDs in
all levels" is their key interest, but they will look into horizontal chemicals issues also.
) suggested that PAN checks the information publicly available or already
received and then asks for precise documents to "fill in the gaps" of their specific request
focused on ED and TTIP. Asking for all documents related to ‘chemicals and TTIP’
would produce a huge amount of documents not at all focused on ED. This would not
satisfy the objective of the request. Moreover, it would take much more time, as the
documents would need to be treated in batches, given the high amount of them. In order
not to lose time on both side, it would be very much appreciated if PAN could better
detail its request, following the clarifications provided from both sides during this
meeting. PAN agreed to this and promised to come back with clarifications to their
request in the coming days.
* * *